Shimizu, Daisuke
Miyazaki, Dai http://orcid.org/0000-0002-1647-4708
Ehara, Fumie
Shimizu, Yumiko
Uotani, Ryu
Inata, Koudai
Sasaki, Shin-ichi
Inoue, Yoshitsugu
Funding for this research was provided by:
Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Science, and Culture (15K20261)
Article History
Received: 19 February 2019
Revised: 28 July 2019
Accepted: 2 August 2019
First Online: 13 August 2019
Compliance with ethical standards
:
: Daisuke Shimizu declares that he has no conflict of interest.Dai Miyazaki reports a speaker honorarium from Santen Pharmaceutical, a speaker honorarium from Senju Pharmaceutical, and a speaker honorarium from Alcon, outside the submitted work.Fumie Ehara declares that she has no conflict of interest.Yumiko Shimizu declares that she has no conflict of interest.Ryu Uotani declares that he has no conflict of interest.Koudai Inata declares that he has no conflict of interest.Shin-ichi Sasaki has received research grants from the Japanese Ministry of Education, Science, and Culture (Grant-in-Aid 15K20261 for Scientific Research).Yoshitsugu Inoue reports grants and a speaker honorarium from Senju Pharmaceutical Co., Ltd., grants from Santen Pharmaceutical Co., Ltd., and grants from Alcon Japan, Ltd., outside the submitted work.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.